Bank of Nova Scotia (BNS)

Bancos — Canadá y América Latina

Scotiabank is the most internationally diversified of the large Canadian banks and comes off two years of simplifying its footprint: it exited Colombia, Costa Rica and Panama and sold its consumer finance business in Peru, redirecting capital to the North American corridor with stakes in KeyCorp and Davivienda Group. The net interest margin expansion — from 2.16% in fiscal 2024 to 2.49% in the quarter ended July 2026 — is already in earnings and also in the price: the stock trades above the exit band that corresponds to a bank. The estimated return is +5% annually and the status is Fairly valued.

Moat Compounder estimates the intrinsic value of Bank of Nova Scotia (BNS) at $93 per share on a five-year horizon. With the stock at $88.80 at 2026-10-12 close, the expected total return is 5.0% per year: fairly valued. The analysis draws on 40-F fiscal 2025 (closed Oct-31-2025) and 6-K — third-quarter 2026 results (closed July 31, 2026). Analysis dated 2026-08-25.

Price
$88.80
at 2026-10-12 close
Intrinsic value (5y, base)
$93
Total annual return (5y)
5.0%
1.0% price · 4.0% div
Status (nominal)
Fairly valued
Margin of safety
+2%

The essentials

  • The net interest margin expanded 33 basis points in two years (2.16% in fiscal 2024 to 2.49% in the second quarter of 2026) and explains most of the earnings jump; it is balance-sheet repricing, not volume growth.
  • Reported 2025 earnings were depressed by a CAD 1,422 million impairment from divestitures that has already rolled out of the twelve-month window, so the recent comparison runs against a low base.
  • Capital is ample: a common equity tier 1 ratio of 13.1% against a regulatory minimum of 11.0% — the prudential supervisor lowered the domestic stability buffer from 3.5% to 3.0% on June 19, 2026 — with CAD 2,182 million in buybacks over the nine months of 2026.
  • The dividend yield is 3.6% and the normalized return on tangible common equity is 16%, within the good-business band but below the higher-quality Canadian peers.
Health: Solid
Price $89 at 2026-10-12 closeMarket Cap CAD 154.4 bnDeposits CAD 1,006 bnP/tangible book 1.7xROTCE 15.7%P/E (today) 15.3x

Intrinsic value — two valuation methods

Fairly valued
Price market
$89
DCF value today
$159
+78.9% vs price
Multiples value today
$91
+2.0% vs price

Total return at 5 years: 4.9%/year = 1.0% appreciation + 4.0% dividend. The target price ($93) is ex-dividend; the $18 in dividends collected over 5 years are added separately.

By both methods, the value today (DCF $159 · Multiples $91) exceeds the market price ($89).

Pillars of the analysis

The verdict — today vs 5 years

Today — fairly valued: at $89 trades ~1.9% below its value discounted to today (~$91); the discount is positive but does not reach the margin of safety we require (≥38%).

At 5 years — En valor: the target price ($93) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.

The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$58.

Thesis

The business

A Canadian universal bank with an international franchise in simplification. Quality is solid, not exceptional: normalized return on tangible common equity of 15.7%, ample capital with a common equity tier 1 ratio of 13.1% against a minimum of 11.0%, and a deposit base of CAD 1,006 billion that gives it a funding cost hard to match. The weak point is structural profitability: adjusted return on equity of 13.5% in the nine months ended July 2026 — already recovered from the 9.7% of fiscal 2025, which carried the divestiture impairment — still trails higher-quality Canadian peers and sits below the 14% target the company itself set for fiscal 2027.

The valuation

Equity is valued on earnings, the correct method for a bank: deposits and wholesale debt are operating funding, not the shareholder's capital structure, so building an enterprise-value bridge does not apply. Normalized common earnings for the twelve months ended July 2026 are CAD 10.15 billion, and the base case takes them to CAD 12.89 billion by year five at an exit multiple of 12 times, within the 10-to-15-times band that corresponds to a bank. The result is a value of $93 per share and an estimated return of +5% annually.

The margin of safety

It trades close to intrinsic value, far from the required margin of safety. The math is straightforward: today's entry multiple sits above the ceiling of the band that corresponds to a bank, so the exit valuation implies compression, and that compression eats up nearly all of the earnings growth. The annualized dividend of CAD 4.56 per share, yielding 3.6%, contributes most of the estimated return of +5%. The status is Fairly valued.

What to watch

The disconfirmer is the net interest margin. All of the earnings improvement of the past two years comes from repricing from 2.16% to 2.49%, not from loan-book volume: at Jul-31-2026 the book stood at CAD 770,555 million, barely 1.2% above the CAD 761,560 million a year earlier, with the international banking book down 12% from the Colombia, Costa Rica and Panama transfers and organic growth in Canada, Mexico and Chile. If the Bank of Canada halts the rate-cutting cycle and the margin stabilizes, earnings stop growing at the pace the price discounts. The second point is provision for credit losses, at 0.61% of average net loans over the nine months against 0.62% for fiscal 2025 and 0.53% the year before, against a backdrop of Canadian labor-market weakness and U.S. tariffs.

Educational / informational. Does not constitute investment advice.

Other companies of the same type